Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2020

Feb 20, 2020

30229_dirs_2020-02-20_60d69763-82da-49aa-9c7f-d3d43dfc0e57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2020-02-18

Reporting Person: Rosebrough Walter M Jr (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-18 Ordinary Shares M 44255 $69.72 Acquired 104878 Direct
2020-02-18 Ordinary Shares S 32255 $167.4587 Disposed 72623 Direct
2020-02-19 Ordinary Shares M 40000 $69.72 Acquired 112623 Direct
2020-02-19 Ordinary Shares S 39488 $168.0028 Disposed 73135 Direct
2020-02-19 Ordinary Shares S 512 $168.5918 Disposed 72623 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-18 Employee Stock Option (right to buy) $69.72 M 44255 Disposed 2026-06-01 Ordinary Shares (44255) Direct
2020-02-19 Employee Stock Option (right to buy) $69.72 M 40000 Disposed 2016-06-01 Ordinary Shares (40000) Direct

Footnotes

F1: Price reflects a weighted average sale price for multiple transactions ranging from $167.13 to $168.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: Price reflects a weighted average sale price for multiple transactions ranging from $167.48 to $168.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: Price reflects a weighted average sale price for multiple transactions ranging from $168.50 to $168.79 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: These 72,623 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023.

F5: This option is part of an option to purchase 112,340 STERIS ordinary shares, of which 84,255 have fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 112,340 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.